US Bancorp’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $16.2K | Buy |
926
+11
| +1% | +$192 | ﹤0.01% | 3245 |
|
2025
Q1 | $11.5K | Sell |
915
-19
| -2% | -$239 | ﹤0.01% | 3378 |
|
2024
Q4 | $9.85K | Sell |
934
-17,746
| -95% | -$187K | ﹤0.01% | 3414 |
|
2024
Q3 | $271K | Buy |
18,680
+18,525
| +11,952% | +$269K | ﹤0.01% | 1873 |
|
2024
Q2 | $1.32K | Hold |
155
| – | – | ﹤0.01% | 3753 |
|
2024
Q1 | $1.58K | Hold |
155
| – | – | ﹤0.01% | 3745 |
|
2023
Q4 | $849 | Buy |
+155
| New | +$849 | ﹤0.01% | 3799 |
|
2022
Q1 | – | Sell |
-1,843
| Closed | -$12K | – | 4153 |
|
2021
Q4 | $12K | Buy |
1,843
+1,597
| +649% | +$10.4K | ﹤0.01% | 3339 |
|
2021
Q3 | $2K | Sell |
246
-68
| -22% | -$553 | ﹤0.01% | 3878 |
|
2021
Q2 | $10K | Buy |
314
+266
| +554% | +$8.47K | ﹤0.01% | 3383 |
|
2021
Q1 | $2K | Buy |
+48
| New | +$2K | ﹤0.01% | 3698 |
|